176 related articles for article (PubMed ID: 25633935)
1. Effects of 1,2,3,4-tetrahydroisoquinoline derivatives on dopaminergic spontaneous discharge in substantia nigra neurons in rats.
Chiba H; Sato H; Abe K; Saito T; Horiguchi Y; Nojima H; Taguchi K
Pharmacology; 2015; 95(1-2):87-94. PubMed ID: 25633935
[TBL] [Abstract][Full Text] [Related]
2. Effects of 1-cyclohexyl- and 1-cyclohexyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline on dopaminergic spontaneous discharge in nigral neurons of rats.
Abe M; Munakata H; Abe K; Saito T; Horiguchi Y; Nojima H; Taguchi K
Brain Res Bull; 2016 Mar; 121():201-8. PubMed ID: 26876935
[TBL] [Abstract][Full Text] [Related]
3. Properties of 3-methyl-TIQ and 3-methyl-N-propargyl-TIQ for preventing MPTP-induced parkinsonism-like symptoms in mice.
Saitoh K; Abe K; Chiba T; Katagiri N; Saitoh T; Horiguchi Y; Nojima H; Taguchi K
Pharmacol Rep; 2013; 65(5):1204-12. PubMed ID: 24399716
[TBL] [Abstract][Full Text] [Related]
4. Preventative effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives (
Munakata H; Ishikawa R; Saitoh T; Kambe T; Chiba T; Taguchi K; Abe K
Can J Physiol Pharmacol; 2022 Jul; 100(7):594-611. PubMed ID: 35413210
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
Brain Res Bull; 2001 Sep; 56(1):55-60. PubMed ID: 11604249
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.
Ishiwata K; Koyanagi Y; Abe K; Kawamura K; Taguchi K; Saitoh T; Toda J; Senda M; Sano T
J Neurochem; 2001 Nov; 79(4):868-76. PubMed ID: 11723179
[TBL] [Abstract][Full Text] [Related]
7. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
Aoki E; Yano R; Yokoyama H; Kato H; Araki T
Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
[TBL] [Abstract][Full Text] [Related]
8. Single administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline increases the extracellular concentration of dopamine in rat striatum.
Katagiri N; Abe K; Kitabatake M; Utsunomiya I; Horiguchi Y; Hoshi K; Taguchi K
Neuroscience; 2009 Jun; 160(4):820-8. PubMed ID: 19285542
[TBL] [Abstract][Full Text] [Related]
9. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity.
Choi JY; Jang EH; Park CS; Kang JH
Free Radic Biol Med; 2005 Mar; 38(6):806-16. PubMed ID: 15721991
[TBL] [Abstract][Full Text] [Related]
10. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
11. Reduction of 1-methyl 1,2,3,4-tetrahydroisoquinoline level in substantia nigra of the aged rat.
Ayala A; Parrado J; Cano J; Machado A
Brain Res; 1994 Feb; 638(1-2):334-6. PubMed ID: 8199872
[TBL] [Abstract][Full Text] [Related]
12. Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice.
Bian GL; Wei LC; Shi M; Wang YQ; Cao R; Chen LW
Brain Res; 2007 May; 1150():55-61. PubMed ID: 17397812
[TBL] [Abstract][Full Text] [Related]
13. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
[TBL] [Abstract][Full Text] [Related]
14. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L
Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
[TBL] [Abstract][Full Text] [Related]
16. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
17. 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.
Tasaki Y; Makino Y; Ohta S; Hirobe M
J Neurochem; 1991 Dec; 57(6):1940-3. PubMed ID: 1940911
[TBL] [Abstract][Full Text] [Related]
18. Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice.
Zou L; Xu J; Jankovic J; He Y; Appel SH; Le W
Neurosci Lett; 2000 Mar; 281(2-3):167-70. PubMed ID: 10704769
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment.
Shaw VE; Spana S; Ashkan K; Benabid AL; Stone J; Baker GE; Mitrofanis J
J Comp Neurol; 2010 Jan; 518(1):25-40. PubMed ID: 19882716
[TBL] [Abstract][Full Text] [Related]
20. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]